Anaptysbio (ANAB) Retained Earnings (2016 - 2026)
Anaptysbio (ANAB) reported Retained Earnings of -$146000.0 for Q1 2026, down 190.68% on a YoY basis from $161000.0 in Q1 2025, and up 99.98% quarter-over-quarter from -$772.6 million in Q4 2025.
Anaptysbio (ANAB) Retained Earnings (2016 - 2026) Analysis & Trends
Anaptysbio has reported Retained Earnings for 11 years, with the latest figure at -$146000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 190.68% year-over-year to -$146000.0; the trailing twelve-month figure through Mar 2026 stood at -$146000.0 (down 190.68% YoY), and the FY2025 full-year result was -$772.6 million, down 1.74% from the prior year.
- Retained Earnings for Q1 2026 stood at -$146000.0, up from -$772.6 million in the prior quarter.
- The five-year high for Retained Earnings was $759000.0 in Q3 2024, with the low at -$822.2 million in Q3 2025.
- Historically, Retained Earnings has averaged -$178.8 million across 5 years, with a median of -$3.3 million in 2023.
- Annual changes were most pronounced in 2024 — Retained Earnings jumped 132.3% — and 2025, when it plunged 108423.19%.
- Anaptysbio's Retained Earnings stood at -$5.2 million in 2022, then surged by 84.81% to -$797000.0 in 2023, then slumped by 95173.15% to -$759.3 million in 2024, then fell by 1.74% to -$772.6 million in 2025, then soared by 99.98% to -$146000.0 in 2026.
- The last three Retained Earnings figures came in at -$146000.0 (Q1 2026), -$772.6 million (Q4 2025), and -$822.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Anaptysbio | 1.66 Bn | 1.38 Bn | - | -146,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -146,000.00 |
| Dec 31, 2025 | -772.56 Mn |
| Sep 30, 2025 | -822.17 Mn |
| Jun 30, 2025 | -6,000.00 |
| Mar 31, 2025 | 161,000.00 |
| Dec 31, 2024 | -759.33 Mn |
| Sep 30, 2024 | 759,000.00 |
| Jun 30, 2024 | -415,000.00 |
| Mar 31, 2024 | -658.03 Mn |
| Dec 31, 2023 | -797,000.00 |
| Sep 30, 2023 | -2.35 Mn |
| Jun 30, 2023 | -3.61 Mn |
| Mar 31, 2023 | -3.27 Mn |
| Dec 31, 2022 | -5.25 Mn |
| Sep 30, 2022 | -6.01 Mn |
| Jun 30, 2022 | -3.86 Mn |
| Mar 31, 2022 | -2.43 Mn |
| Dec 31, 2021 | -422,000.00 |
| Sep 30, 2021 | -289.22 Mn |
| Jun 30, 2021 | -176,000.00 |